Navigation Links
Statement from CHPA on Today's FDA Advisory Committee Meeting on Dextromethorphan
Date:9/14/2010

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ --  The Consumer Healthcare Products Association issued the following statement on the Drug Safety and Risk Management Advisory Committee's recommendation not to schedule over-the-counter (OTC) medicines containing dextromethorphan:

"Today's FDA advisory committee decision not to recommend scheduling OTC cough medicines containing dextromethorphan as a controlled substance reflects a sound balancing of the benefits of over-the-counter medicines containing dextromethorphan.

"Today, 40 million American households turn to dextromethorphan-containing OTC medicines each year to relieve their cough symptoms. More common than heartburn and severe headaches, cough burdens the sufferer, families, and society (as a very rapid way to spread virus).  Because of cough's widespread prevalence and effects, it's vital for people to have OTC access to safe and effective self-treatment. Dextromethorphan is in nearly 90 percent of OTC cough suppressants sold today. We agree that dextromethorphan should not be scheduled as a controlled substance.

"We do, however, recognize the need for continued education to keep any abuse levels low. We also have long called for federal legislation that would limit purchases of bulk quantities of dextromethorphan to manufacturers who are registered with FDA. We believe that a statutory ban on sales of dextromethorphan medicines to those under 18 would limit abuse. We also believe legislation must be matched with targeted research-based education, which has been shown to be effective in reducing substance abuse.

"Research over the past 35 years clearly shows that targeted educational interventions focusing on increased parental awareness and increased perceptions of the risks and social disapproval are the most effective abuse-reduction strategies. Since 2003, we have had educational programs focusing on the dangers of misuse of over-the-counter medicines, including those containing dextromethorphan. We will continue to expand upon these programs through our comprehensive Abuse Mitigation Plan that targets the key risk factors leading to abuse, along with limiting the various points where teens are accessing these medicines.

"It is our hope that FDA will follow the advisory committee's guidance and weigh the important public benefit of continued over-the-counter access to these medicines in making its final recommendation."

CHPA is the 129-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.

www.chpa-info.org

www.chpa-info.org/pressroom/2010PK_DXM.aspx


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
2. Statement from Eli Lilly and Company Regarding Approval Recommendation from FDA Advisory Committee for Expanding the Pain Indications for Cymbalta® to a Broader Pain Population
3. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
4. NCPA Statement on CVS Caremark-Aetna Agreement
5. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
6. Dendreon Statement on CMS National Coverage Analysis
7. NORD Calls for Statement of Policy on Orphan Drug Development
8. Teva Admits to Making False Statements in US Gianvi™ Label and Agrees to Corrective Measures
9. Alexza Pharmaceuticals Files Shelf Registration Statement
10. FDA Issues Statement on Baxters Recall of Colleague Infusion Pumps
11. Pew Statement on the Physician Payments Sunshine Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Oregon and PUNE, India , ... published by Allied Market Research, titled, "Breast Imaging Technologies Market ... that the global breast imaging technologies market size was valued ... $4,502 million by 2022, growing at a CAGR of 8.4% ... and Europe together accounted for over ...
(Date:1/18/2017)... JOSE, Calif. , Jan. 18, 2017  Adaptive Sound ... announced today a new partnership with Hyatt Place Nashville/Downtown ... by providing ASTI LectroFan sleep therapy machines in over ... one of the most important parts of having a ... , general manager of Hyatt Place Nashville/Downtown. "We,re pleased ...
(Date:1/18/2017)...  Kratom leaves, from a South East Asian ... to prepare tea-like beverages and commercially manufactured products ... to increase alertness, enhance well-being and occupational performance, ... and pains. PinneyAssociates, review of the scientific evidence ... and DEA in determining the most appropriate regulatory ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... For the ... Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity event ... more commonly known as Lou Gehrig's disease or motor neurone disease, is a ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... 2017 Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. ... http://www.createrealimpact.com . , Educational grants totaling $15,000 will be awarded for the ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Bill Howe ... collaboration with the American Heart Association; “Howe” Healthy is Your Heart Drawing Contest ... healthy and active. Each year, Bill Howe Plumbing, Heating & Air receives over 600 ...
(Date:1/19/2017)... ... ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today that it ... years SFI has been recognized as the world’s leader in Intelligent Sales Outsourcing Solutions. ... market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, Ariello, Inc. ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
Breaking Medicine News(10 mins):